Clinical trial / 2007
Coadministration of zinc carnosine led to no significant increase in indomethacin-induced gut permeability in healthy volunteers.
In a randomized crossover trial of 10 healthy volunteers, indomethacin caused a threefold increase in gut permeability in the control arm, with lactulose:rhamnose ratios shifting from mean (SEM) 0.35 (0.035) to 0.88 (0.11) after 5 days (p<0.01). In contrast, no significant increase in gut permeability was seen when zinc carnosine was coadministered. In accompanying preclinical work, zinc carnosine stimulated epithelial cell migration and proliferation and reduced gastric and small-intestinal injury.
- Study type
- Randomized crossover trial and preclinical study
- Who was studied
- 10 healthy volunteers (plus cell and animal models)
- What was measured
- Gut permeability and epithelial repair
THE PAPER
Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes.
Mahmood A, FitzGerald AJ, Marchbank T, Ntatsaki E, Murray D, Ghosh S, Playford RJ. Gut, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.